One compound has multiple Phase 3 RCTs and regulatory review
The data showed an increased insulin secretion occurred after 30 min of glucose administration (3 g/kg), when blood glucose is higher, but not in the absence of a glucose challenge
Like the heart-disease route, MASH coverage flows through regular Part D rather than Bridge, and it comes with prior authorization
More than 12 million Americans take a prescription GLP-1 treatment like Wegovy, Ozempic, or Zepbound
Jellin JM, Batz F, Hitchens K
Many of them share a common thread: They had long held off on using GLP-1s due to barriers such as high out-of-pocket costs for injections or a fear of needles